The IFNbeta treatment of multiple sclerosis (MS) in clinical practice: the experience at the MS Center of Bari, Italy.
Trojano, M
The IFNbeta treatment of multiple sclerosis (MS) in clinical practice: the experience at the MS Center of Bari, Italy. [electronic resource] - Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology Dec 2005 - S179-82 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article
1590-1874
10.1007/s10072-005-0511-9 doi
Adjuvants, Immunologic--therapeutic use
Adult
Cohort Studies
Disability Evaluation
Disease-Free Survival
Female
Follow-Up Studies
Humans
Interferon beta-1a
Interferon beta-1b
Interferon-beta--therapeutic use
Italy
Male
Middle Aged
Multiple Sclerosis, Chronic Progressive--drug therapy
Multiple Sclerosis, Relapsing-Remitting--drug therapy
Population Surveillance
Product Surveillance, Postmarketing
Prospective Studies
Secondary Prevention
Treatment Outcome
The IFNbeta treatment of multiple sclerosis (MS) in clinical practice: the experience at the MS Center of Bari, Italy. [electronic resource] - Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology Dec 2005 - S179-82 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article
1590-1874
10.1007/s10072-005-0511-9 doi
Adjuvants, Immunologic--therapeutic use
Adult
Cohort Studies
Disability Evaluation
Disease-Free Survival
Female
Follow-Up Studies
Humans
Interferon beta-1a
Interferon beta-1b
Interferon-beta--therapeutic use
Italy
Male
Middle Aged
Multiple Sclerosis, Chronic Progressive--drug therapy
Multiple Sclerosis, Relapsing-Remitting--drug therapy
Population Surveillance
Product Surveillance, Postmarketing
Prospective Studies
Secondary Prevention
Treatment Outcome